Good MorningThe market closed the day and the week lower on Friday. The week’s action was driven by a combination of fear and hope, fear that COVID 19 will cause another massive economic shutdown and hope that Congress will pass a stimulus bill. On the one hand, COVID-19 cases are on the rise with what is expected to be the worst of the pandemic still ahead of us. On the other, Congress passed a stop-gap measure to avoid a government shut-down for one week in hopes a stimulus bill can be passed.
Investors banking on another round of stimulus should take caution. If passed as is, the current stimulus bill is far less than the $2.8 trillion the summer stock market rally was built on. In that light, the passage of the bill could result in a sell-the-news event that takes the market back down to a firmer support zone.
Featured: Sell these "safe" blue chips immediately (Ad) 
|
Consumer Discretionary | | Hooker Furniture; The Rebound Accelerates
It has been a bit of a hit-or-miss year for the furniture makers. While demand is high, operating results are heavily dependent on the ability to meet demand. For many, supply chain disruptions that began well before the pandemic persisted into the 2nd half... Read the Full Story |
|
From Our Partners | | Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | | Watch the full story and see the verified track record for yourself |
|
Technology | |
With corporate borrowing rates at historic lows, most companies have opted to tap into the debt market to bolster liquidity and fund growth initiatives. But others have stayed clear of debt instead preferring to rely solely on the equity markets.
There are merits to both capital raising approache... Read the Full Story |
|
Communication Services | |
Although telecom stocks don’t always make the headlines in today’s market, it’s important to recognize the value in buying companies that offer decent growth potential combined with relatively stable and consistent earnings. Telecom companies help to keep the world connected by a... Read the Full Story |
|
From Our Partners | | Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.
It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.
Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States. | | Click here to learn about this new era of medical technology |
|
Consumer Discretionary | |
One of the greatest economic principles around is the notion of scarcity. When something is scarce—or hard to find, if you prefer—it's inherently worth more because it's that much harder to meet demand. Of course, it also depends on there being some demand for the item in question, but... Read the Full Story |
|
Consumer Discretionary | | Johnson Outdoors Isn’t Just Trolling Motors
Johnson Outdoors (NASDAQ:JOUT) is one of those hum-drum investments that tends to not get much spotlight. The company makes outdoor electronics including trolling motors, depth finders, and other high-tech gear for fishermen, camping, and campers (r... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Consumer Discretionary | |
RH; Shifting Trends Are Driving Profits
There have been some big changes in the furniture industry over the past few years. The trade war accelerated the flight out of China, operational efficiency became a priority, and now the stage is set for big gains. Companies like RH (NYSE: RH) (formerly k... Read the Full Story |
|
Finance | | It might have taken them a bit longer than expected to undo the damage done back in March but shares of fintech Fiserv (NASDAQ: FISV) are closing the gap fast. With only a few trading days left in 2020 they look good value to close out the year higher than where they started and at all time highs.
... Read the Full Story |
|
Communication Services | |
With so many large-cap companies in focus these days, now might be a good time for investors to recall that there are plenty of advantages associated with investing in small-cap stocks. These are companies that have a market capitalization between $300 million to $2 billion and offer tons of growt... Read the Full Story |
|
Consumer Discretionary | | The Lovesac Company Is Growing And Growing Strong
The Lovesac Company (NASDAQ:LOVE) is one of those stocks I just happened to run across one day and am glad I did. To call it a microcap is an overstatement. The company’s newly reported Q3 revenue is a mere $75 million and barely a blip on the... Read the Full Story |
|
Consumer Discretionary | |
On the surface, this would seem to be the best possible time to buy in on Best Buy (NYSE:BBY). Pretty much the leading electronics retailer around, going into the height of the holiday season, it's a situation that seems tailor-made to buy in on big profits. So why did Goldman Sachs shift its rati... Read the Full Story |
|
The Early Bird Stock Of The Day Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. | | View Today's Stock Pick |
|
